The Time in Range (TIR) initiative encourages using and monitoring blood glucose levels beyond A1C. The American Diabetes Association® wants to increase awareness and education to empower patients and clinicians to use TIR data from continuous glucose monitors and blood glucose meters for treatment and lifestyle decisions that improve quality of life and outcomes. 

The ADA’s Time in Range initiative will provide guidance on treating your patients with diabetes who might benefit from time in range. Access new TIR webinars, podcast episodes, and practice pearl videos by registering. 

Time in Range is supported, in part by, Abbott and LifeScan.